Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MabVax Therapeutics Holdings Inc (NASDAQ:MBVX)

3.80
Delayed Data
As of Dec 02
 +0.23 / +6.44%
Today’s Change
3.03
Today|||52-Week Range
7.18
-25.03%
Year-to-Date

Today’s Trading

Previous close3.57
Today’s open3.69
Day’s range3.62 - 4.00
Volume50,211
Average volume (3 months)97,730
Market cap$23.9M
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+80.86%
Earnings growth (this year)--
Earnings growth (next 5 years)+54.00%
Revenue growth (last year)+303.29%
P/E ratioNM
Price/Sales10.73
Price/Book1.96

Competitors

 Today’s
change
Today’s
% change
SBOTStellar Biotechnolog...+0.27+12.11%
TKAITokai Pharmaceutical...+0.02+1.96%
PARNParnell Pharmaceutic...+0.02+1.55%
IMNPImmune Pharmaceutica...+0.00+2.78%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateMarch 14, 2017
EPS forecast (this quarter)-$6.36
Annual revenue (last year)$1.3M
Annual profit (last year)-$18.1M
Net profit margin-1,428.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
John David Hansen
Chief Financial Officer
Gregory P. Hanson
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs